Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,354,769
+$621,564 QoQ
Shares Held
100,279
+70.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Swiss Life Asset Management Ltd holds $41,003,042 across 18 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
174,361 | $20,611,212 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
15,776 | $9,354,852 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
101,990 | $3,071,938 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
20,740 | $2,732,287 | |
| 5 | VTRS |
Viatris Inc
This page
|
100,279 | $1,354,769 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
44,011 | $1,053,183 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
19,034 | $580,156 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
5,872 | $348,033 |
All Filings in VTRS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,354,769 | 100,279 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $733,205 | 58,892 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $819,264 | 82,754 | Shares | Defined | 2025-12-02 | |
| 2025-06-30 | $818,889 | 91,701 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $1,002,651 | 115,115 | Shares | Defined | 2025-12-02 | |
| 2024-12-31 | $1,496,588 | 120,208 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $242,370 | 20,876 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $4,011,960 | 402,000 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $3,867,240 | 402,000 | Shares | Sole | 2025-12-09 | |
| 2022-12-31 | $297,204 | 26,703 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $306,702 | 35,998 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $494,591 | 47,239 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $568,609 | 52,262 | Shares | Defined | 2025-12-09 | |
| 2021-12-31 | $544,122 | 40,216 | Shares | Sole | 2025-12-29 | |
| 2021-09-30 | $544,926 | 40,216 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $567,712 | 39,728 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $548,182 | 39,240 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $693,697 | 37,017 | Shares | Defined | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||